"Core Scientific (CORZ) faces challenges as a major shareholder threatens a $9 billion merger with CoreWeave, contributing to a decline in share prices. The overall sentiment remains cautious, with analysts maintaining a hold rating amid uncertainties surrounding the merger's viability and the company's strategic direction."